Proto Labs Inc PRLB
Proto Labs Inc financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $533.1M | $500.9M | $503.9M | $488.4M | $488.1M | $434.4M | $458.7M | $445.6M | $344.5M | $298.1M |
| Gross profit | $237.1M | $223.2M | $222.0M | $215.5M | $222.7M | $217.8M | $235.3M | $238.7M | $193.8M | $166.9M |
| R&D expense | $42.8M | $41.3M | $40.1M | $38.2M | $44.2M | $36.9M | $32.7M | $28.7M | $23.6M | $22.4M |
| Operating income | $25.1M | $19.9M | $28.2M | -$98.0M | $40.3M | $59.8M | $79.9M | $88.9M | $72.2M | $61.8M |
| Income tax | $9.8M | $8.1M | $10.7M | $5.6M | $6.8M | $12.1M | $17.5M | $15.1M | $22.7M | $21.5M |
| Net income | $21.2M | $16.6M | $17.2M | -$103.5M | $33.4M | $50.9M | $63.7M | $76.6M | $51.8M | $42.7M |
| EPS (diluted) | $0.88 | $0.66 | $0.66 | $-3.77 | $1.21 | $1.89 | $2.35 | $2.81 | $1.93 | $1.61 |
| Operating cash flow | $74.5M | $77.8M | $73.3M | $62.1M | $55.2M | $107.0M | $116.1M | $122.9M | $81.7M | $77.5M |
| Free cash flow | $59.7M | $68.7M | $45.2M | $40.4M | $21.0M | $60.0M | $53.8M | $35.8M | $49.1M | $43.9M |
| Cash & equivalents | $110.8M | $89.1M | $83.8M | $56.6M | $65.9M | $127.6M | $125.2M | $85.0M | $36.7M | $68.8M |
| Inventory | $14.4M | $12.3M | $13.7M | $13.6M | $13.2M | $10.9M | $10.1M | $10.1M | $11.3M | $9.3M |
| Total assets | $763.4M | $743.5M | $772.4M | $802.2M | $928.6M | $744.2M | $673.7M | $619.0M | $518.7M | $414.2M |
| Total liabilities | $89.5M | $73.4M | $77.1M | $104.5M | $100.1M | $99.8M | $87.9M | $77.5M | $57.5M | $34.4M |
| Shareholders' equity | $673.9M | $670.2M | $695.3M | $697.6M | $828.5M | $644.4M | $585.8M | $541.5M | $461.2M | $379.8M |
Growth · year-over-year · Revenue CAGR 6.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +6.4% | -0.6% | +3.2% | +0.1% | +12.4% | -5.3% | +2.9% | +29.3% | +15.6% | +12.9% |
| Net income growth | +28.0% | -3.6% | — | -410.0% | -34.4% | -20.1% | -16.9% | +47.9% | +21.2% | -8.2% |
| EPS growth | +33.3% | +0.0% | — | -411.6% | -36.0% | -19.6% | -16.4% | +45.6% | +19.9% | -9.0% |
| Free cash flow growth | -13.1% | +52.0% | +11.8% | +92.0% | -64.9% | +11.4% | +50.2% | -27.1% | +11.9% | +122.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.